KCNN4 and cancer: The results showed that the expression level of KCNN4 in pan-cancer had a Pearson correlation of −0.04, 0.15, and 0.21 with cisplatin (Figure 8(c)), sorafenib (Figure 8(d)), and sunitinib (Figure 8(e)), respectively.